The European Medicines Agency’s (EMA) Guideline on good pharmacovigilance practices (GVP), Module IV requires that risk-based audits of the quality system be performed at regular intervals to assure that it complies with the established quality requirements and to determine its effectiveness. It includes audit of the pharmacovigilance system which is covered by the quality system.
The GVP Modules are applicable to EU-based companies and any company marketing medicinal products on a global basis. The legally required risk based audit strategy shall cover all PV processes and tasks undertaken by or delegated to other departments, MAH affiliates, and third parties such as distributors, external service providers, and partners. The PV Audit Strategy Plan is used to prepare the PV audit program, i.e. annual PV Audit Schedule.
Why You Should Attend:
In this session we will review the EMA and FDA requirements regarding Risk Based Audits of the PV system and Quality System. We will focus on the design of the safety, pharmacovigilance (PV) audit strategy, identification of the PV processes and entities subject to PV audit, development of risk assessment methodology, and development of procedures / tools to monitor PV processes and activities, and implementation of the PV audit strategy plan.
Areas Covered in the Session :
Review the EMA PV Modules at the basic level
Recognize post-marketing PV expectations and compliance on a global level
Understand the FDA and EMEA’s requirements for a risk based audit program and current interpretation.
Determine PV reporting responsibilities applicable to global PV submissions
Plan, develop and implement the PV Audit Strategy Plan
Identify the PV activities and processes subject to PV audit
Develop risk assessment criteria
Identify the PV audit scope and entities subject to PV audit
Categorize the entities subject to PV audit
Perform risk assessments
Prioritize entities for audit according to relative risk
Apply basic auditing concepts to assess PV compliance
Who Should Attend:
PV Quality Assurance Staff
PV Compliance professionals
Quality auditors
Pharmacovigilance Auditors
Relevant Pharmacovigilance Staff
PV Service Provider Relationship Managers
MAH Affiliates responsible for Pharmacovigilance
Heads of Pharmacovigilance Quality Assurance Departments
Auditors transitioning into pharmacovigilance auditing
Drug Safety Staff
Medical Information Staff
Safety Physicians